# Ligand Pharmaceuticals Inc: filings

LGND · Nasdaq · CIK 886163 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lgnd.md) · [Financials](/companies/lgnd/financials.md) · [Filings](/companies/lgnd/filings.md) · [Insiders](/companies/lgnd/insiders.md)

## Reports and events: 477 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 718, 8-K 337, SC 13G/A 88, 144 65, 10-Q 54, CT ORDER 44, 425 25, 4/A 24, SC 13G 24, DEFA14A 23, UPLOAD 22, DEF 14A 20, 3 19, CORRESP 19, 10-K 18, 8-K/A 14, SC 13D/A 13, 10-Q/A 10, S-8 10, SCHEDULE 13G/A 7, 10-K/A 5, ARS 4, EFFECT 4, S-3ASR 4, SC 13D 3, SCHEDULE 13G 3, SC TO-T/A 3, 144/A 2, 3/A 2, 424B3 2, 424B5 2, 5 2, NT 10-Q 2, PRE 14A 2, S-3 2, S-4 2, S-4/A 2, SCHEDULE 13D 2, SC TO-C 2, D 1, PRER14A 1, S-3/A 1, SCHEDULE 13D/A 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:47 ET | [10-Q](/filings/0000886163-26-000060.md) | Quarterly report, period 2026-09-30 | 0000886163-26-000060 |
| 2026-10-29 | 07:14 ET | [8-K](/filings/0000886163-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000058 |
| 2026-09-24 | 07:15 ET | [8-K](/filings/0000886163-26-000054.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0000886163-26-000054 |
| 2026-09-22 | 07:08 ET | [8-K](/filings/0000886163-26-000050.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-26-000050 |
| 2026-09-02 | 16:08 ET | [8-K/A](/filings/0000886163-26-000048.md) | 9.01 Financial statements and exhibits | 0000886163-26-000048 |
| 2026-08-07 | 16:06 ET | [10-Q](/filings/0000886163-26-000044.md) | Quarterly report, period 2026-06-30 | 0000886163-26-000044 |
| 2026-08-06 | 07:05 ET | [8-K](/filings/0000886163-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000041 |
| 2026-07-14 | 09:20 ET | [8-K](/filings/0001193125-26-302660.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302660 |
| 2026-06-25 | 17:00 ET | [8-K](/filings/0001193125-26-282990.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-282990 |
| 2026-06-22 | 07:11 ET | [8-K](/filings/0001193125-26-276694.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276694 |
| 2026-06-09 | 16:02 ET | [8-K](/filings/0000886163-26-000038.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000886163-26-000038 |
| 2026-05-18 | 09:01 ET | [8-K](/filings/0001193125-26-228003.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-228003 |
| 2026-05-08 | 16:14 ET | [10-Q](/filings/0000886163-26-000034.md) | Quarterly report, period 2026-03-31 | 0000886163-26-000034 |
| 2026-05-07 | 07:03 ET | [8-K](/filings/0000886163-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000030 |
| 2026-05-01 | 21:15 ET | [SCHEDULE 13D](/filings/0001193125-26-202033.md) | Ownership report, active investor | 0001193125-26-202033 |
| 2026-04-30 | 16:41 ET | [8-K](/filings/0000886163-26-000027.md) | 1.02 Termination of a material agreement | 0000886163-26-000027 |
| 2026-04-27 | 09:29 ET | [8-K](/filings/0001193125-26-179529.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001193125-26-179529 |
| 2026-04-21 | 16:02 ET | [DEF 14A](/filings/0000886163-26-000021.md) | Proxy statement, period 2025-12-31 | 0000886163-26-000021 |
| 2026-02-27 | 16:02 ET | [10-K](/filings/0000886163-26-000006.md) | Annual report, period 2025-12-31 | 0000886163-26-000006 |
| 2026-02-26 | 07:05 ET | [8-K](/filings/0000886163-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000003 |
| 2025-12-18 | 16:11 ET | [8-K](/filings/0001193125-25-324830.md) | 7.01 Regulation FD disclosure | 0001193125-25-324830 |
| 2025-11-10 | 16:42 ET | [SCHEDULE 13D/A](/filings/0001193125-25-274432.md) | Ownership report, active investor, amended | 0001193125-25-274432 |
| 2025-11-07 | 16:04 ET | [10-Q](/filings/0000886163-25-000063.md) | Quarterly report, period 2025-09-30 | 0000886163-25-000063 |
| 2025-11-06 | 07:08 ET | [8-K](/filings/0000886163-25-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000058 |
| 2025-09-16 | 17:19 ET | [8-K](/filings/0001193125-25-205147.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-205147 |
| 2025-08-14 | 16:41 ET | [8-K](/filings/0001193125-25-180841.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180841 |
| 2025-08-11 | 07:25 ET | [8-K](/filings/0001193125-25-177452.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-177452 |
| 2025-08-08 | 16:12 ET | [10-Q](/filings/0000886163-25-000051.md) | Quarterly report, period 2025-06-30 | 0000886163-25-000051 |
| 2025-08-07 | 07:04 ET | [8-K](/filings/0000886163-25-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000047 |
| 2025-07-03 | 16:05 ET | [SCHEDULE 13D](/filings/0000950170-25-093838.md) | Ownership report, active investor | 0000950170-25-093838 |
| 2025-07-02 | 07:10 ET | [8-K](/filings/0000886163-25-000042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-25-000042 |
| 2025-06-09 | 16:03 ET | [8-K](/filings/0000886163-25-000040.md) | 5.07 Shareholder vote results | 0000886163-25-000040 |
| 2025-05-09 | 16:04 ET | [10-Q](/filings/0000886163-25-000036.md) | Quarterly report, period 2025-03-31 | 0000886163-25-000036 |
| 2025-05-08 | 07:06 ET | [8-K](/filings/0000886163-25-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000033 |
| 2025-04-22 | 16:07 ET | [DEF 14A](/filings/0000886163-25-000025.md) | Proxy statement, period 2024-12-31 | 0000886163-25-000025 |
| 2025-04-17 | 06:08 ET | [8-K](/filings/0000886163-25-000020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-25-000020 |
| 2025-02-28 | 16:02 ET | [10-K](/filings/0000886163-25-000012.md) | Annual report, period 2024-12-31 | 0000886163-25-000012 |
| 2025-02-27 | 07:06 ET | [8-K](/filings/0000886163-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000008 |
| 2025-02-25 | 16:02 ET | [8-K](/filings/0000886163-25-000003.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-25-000003 |
| 2024-11-08 | 16:01 ET | [10-Q](/filings/0000886163-24-000078.md) | Quarterly report, period 2024-09-30 | 0000886163-24-000078 |
| 2024-11-07 | 07:11 ET | [8-K](/filings/0000886163-24-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-24-000074 |
| 2024-08-07 | 16:30 ET | [10-Q](/filings/0000886163-24-000071.md) | Quarterly report, period 2024-06-30 | 0000886163-24-000071 |
| 2024-08-06 | 16:08 ET | [8-K](/filings/0000886163-24-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-24-000067 |
| 2024-08-02 | 17:15 ET | [8-K](/filings/0000886163-24-000064.md) | 5.02 Departure or appointment of officers or directors | 0000886163-24-000064 |
| 2024-07-17 | 17:10 ET | [8-K](/filings/0000886163-24-000061.md) | 2.01 Completion of an acquisition or disposition | 0000886163-24-000061 |
| 2024-07-10 | 16:02 ET | [8-K](/filings/0000886163-24-000059.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000886163-24-000059 |
| 2024-07-08 | 07:38 ET | [8-K](/filings/0000886163-24-000053.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-24-000053 |
| 2024-06-27 | 09:10 ET | [8-K](/filings/0000886163-24-000051.md) | 8.01 Other events | 0000886163-24-000051 |
| 2024-06-18 | 17:14 ET | [8-K](/filings/0000886163-24-000047.md) | 8.01 Other events | 0000886163-24-000047 |
| 2024-06-17 | 16:02 ET | [8-K](/filings/0000886163-24-000045.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000886163-24-000045 |

Page 1 of 10. [Older](/companies/lgnd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:58 ET. No prices; not investment advice.